CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Schirmer Test IWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug382 Hydroxychloroquine Sulfate 400 mg twice a day Wiki 1.00
drug384 Hydroxychloroquine Sulfate 600 mg twice a day Wiki 1.00
drug383 Hydroxychloroquine Sulfate 600 mg once a day Wiki 1.00
drug627 Placebo oral tablet Wiki 0.22

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D003231 Conjunctivitis NIH 1.00

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Tear Fluid miRNA Analysis in Sars-Cov2 Conjunctivitis

The aim of this study is to assess the virus RNA, and miRNA levels related to viral infection, and inflammatory response in tears of hospitalized patients with a diagnosis of COVID-19 with and without conjunctivitis and to correlate them with clinical condition. Tears will be collected by using Schirmer Test I, a non invasive painless test which can be performed at the patient's bed. Tears will be collected on the graduated paper strips pulling the lower lid gently downward for 5 minutes. Following, the strip will be placed in a 2.0 mL Eppendorf tube and stored at −80◦C (or - 20°C)

NCT04346160 COVID Conjunctivitis Diagnostic Test: Schirmer Test I
MeSH:Conjunctivitis
HPO:Conjunctivitis

Primary Outcomes

Description: - to asses virus RNA and miRNA levels in tears

Measure: virus molecular analysis

Time: 2 weeks

Description: - to asses inflammatory response molecules

Measure: host molecular analysis

Time: 2 weeks

Secondary Outcomes

Description: To analyze the prevalence of conjunctivitis in patients with a diagnosis of COVID-19 and the assessment of the predictive value of conjunctivitis in the development of the COVID-19 disease (or in developing respiratory distress forms-ARDS).

Measure: Epidemiologic data

Time: 2 weeks


Related HPO nodes (Using clinical trials)